Capital Management Associates Inc’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Capital Management Associates Inc's LLY Position: Q2 2026 in Review
Capital Management Associates Inc increased its Eli Lilly (LLY) stake by 8.6% in Q2 2026, buying an estimated $36.8K and bringing the position to 454 shares worth $545K. The position accounts for 0.11% of the portfolio, ranked #99.
Capital Management Associates Inc first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $685K in Q1 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Capital Management Associates Inc held 454 shares of Eli Lilly worth $545K as of Q2 2026.
- Capital Management Associates Inc bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
- Eli Lilly made up 0.11% of Capital Management Associates Inc's portfolio in Q2 2026, its #99 holding.
- Capital Management Associates Inc first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- Capital Management Associates Inc's Eli Lilly position peaked at $685K in Q1 2025.
- 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.